P3 Health Partners Inc (NAS:PIII)

$ 0.205 -0.0087 (-4.07%) Market Cap: 33.39 Mil Enterprise Value: 115.02 Mil PE Ratio: 0 PB Ratio: 0.28 GF Score: 42/100

Q3 2024 P3 Health Partners Inc Earnings Call Transcript
Nov 12, 2024

$0.3904 (-1.31%)

Earnings
Q2 2024 P3 Health Partners Inc Earnings Call Transcript
Aug 07, 2024

$0.6164 (+1.75%)

Earnings
Q1 2024 P3 Health Partners Inc Earnings Call Transcript
May 08, 2024

$0.7461 (+4.57%)

Earnings
Q4 2023 P3 Health Partners Inc Earnings Call Transcript
Mar 28, 2024

$1.03 (+0.98%)

Earnings
P3 Health Partners Inc at JPMorgan Healthcare Conference Transcript
Jan 10, 2024
P3 Health Partners Inc Annual Shareholders Meeting Transcript
Dec 15, 2023
Q3 2023 P3 Health Partners Inc Earnings Call Transcript
Nov 08, 2023

$1.31 (-7.75%)

Earnings
Q2 2023 P3 Health Partners Inc Earnings Call Transcript
Aug 07, 2023

$2.14 (-3.60%)

Earnings
Q1 2023 P3 Health Partners Inc Earnings Call Transcript
May 10, 2023

$2.22 (+8.82%)

Earnings
Q4 2022 P3 Health Partners Inc Earnings Call Transcript
Mar 31, 2023

$1.06 (-3.64%)

Earnings
P3 Health Partners Inc at Barclays Global Healthcare Conference Transcript
Mar 14, 2023
P3 Health Partners Inc at JPMorgan Healthcare Conference Transcript
Jan 12, 2023
P3 Health Partners Inc Annual Shareholders Meeting Transcript
Dec 16, 2022
Foresight Acquisition Corp Definitive Agreement with P3 Health Partners - M&A Call Transcript
May 25, 2021

P3 Health Partners Inc at JPMorgan Healthcare Conference Transcript

Jan 12, 2023 / 01:15AM GMT

Release Date Price: $1.73 (+18.49%)

Transcript 8-K

Steve Tuekam

Hello, everyone, and thank you for joining us this afternoon. My name is Steve Tuekam, and I'm an associate with JPMorgan Healthcare Investment Banking team. Before we start, just a usual reminder that we'll have a Q&A session right after the presentation to the extent time allows.

Today, I'm pleased to introduce to you, P3 Health Partners, a patient-centered, physician-led health care company. We have 2 wonderful speakers, Dr. Sherif Abdou, Chief Executive Officer; and Atul Kavthekar, Chief Financial Officer. I'm sure they're excited to tell you more about the company, and the work their team has been doing to lead health care in a new direction by cultivating wellness and not just managing illness.

With that, I'll pass it over to Dr. Abdou.

Sherif Abdou

P3 Health Partners Inc. - Co-Founder, CEO & Director

Thanks, Steve, and thank you, everybody, for your time today. It's very exciting to be here in person finally. So hopefully, everyone is safe and enjoying the conference so far. So I'm going to get right to the point, since

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.